use of anti-a and anti-b antibody-poor globulin g (igg) concentrate for the treatment of neonatal jaundice due to fetal-maternal incompatibility in the abo system
LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
发明人:
MAZEN ELZAABI
申请号：
BRPI0923032
公开号：
BRPI0923032A2
申请日:
2009.12.16
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
An embodiment relates to the use of an immonuglobulin (IgG) concentrate depleted of anti-A (AcaA) and anti-B (AcaB) antibodies for producing a drug intended for treating neonatal jaundice caused by maternal-fetal incompatibility with respect to the ABO system.
